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Background: Deciphering of the information content of eukaryotic promoters has remained confined to universal
landmarks and conserved sequence elements such as enhancers and transcription factor binding motifs, which are
considered sufficient for gene activation and regulation. Gene-specific sequences, interspersed between the canonical
transacting factor binding sites or adjoining them within a promoter, are generally taken to be devoid of any regulatory
information and have therefore been largely ignored. An unanswered question therefore is, do gene-specific sequences
within a eukaryotic promoter have a role in gene activation? Here, we present an exhaustive experimental analysis of
a gene-specific sequence adjoining the heat shock element (HSE) in the proximal promoter of the small heat shock
protein gene, αB-crystallin (cryab). These sequences are highly conserved between the rodents and the humans.
Results: Using human retinal pigment epithelial cells in culture as the host, we have identified a 10-bp gene-specific
promoter sequence (GPS), which, unlike an enhancer, controls expression from the promoter of this gene, only
when in appropriate position and orientation. Notably, the data suggests that GPS in comparison with the HSE
works in a context-independent fashion. Additionally, when moved upstream, about a nucleosome length of DNA
(−154 bp) from the transcription start site (TSS), the activity of the promoter is markedly inhibited, suggesting its
involvement in local promoter access. Importantly, we demonstrate that deletion of the GPS results in complete
loss of cryab promoter activity in transgenic mice.
Conclusions: These data suggest that gene-specific sequences such as the GPS, identified here, may have critical roles
in regulating gene-specific activity from eukaryotic promoters.
Keywords: Gene-specific promoter sequence, Gene expression, αB-crystallin, Human retinal pigment epithelial cells,
Transgenic miceBackground
A eukaryotic promoter is heterogeneous in structure. It
contains multiple transacting factor binding sites that
are shared amongst multiple genes, yet it contains spe-
cific information for how and when a gene should be
active. Investigations on eukaryotic promoters have
sought a common mechanistic thread in cis-regulatory
modules of enhancer sequences and transcription fac-
tor binding sites (both distant as well as proximal) for* Correspondence: Bhat@jsei.ucla.edu
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unless otherwise stated.an understanding of the control of gene expression [1-3].
There is, however, a finite number of transcription factors
that are shared among a large number of promoters [4] (at
least 70,000 promoters and 1,800 transcription factors)
[5]; thus, combinatorial schemes have been invoked to ex-
plain specific gene activation via a ‘regulatory grammar’
that remains to be deciphered [6-9]. Thus, there is no
known concrete mechanistic detail that explains the
control of specific gene activity [10].
Our understanding of the regulatory information in the
eukaryotic promoters has largely come from functional un-
derstanding of the shared presence of universal or conserved
sequence elements in different genes [1-3,11,12] and has
established a major role for transcription factors (transacting
factors, coactivators, and basal factors) and their binding. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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import of gene-specific sequences, if any, in the regulation
has thus remained uninvestigated. While the commonality of
the sequence elements in the promoters of various genes has
contributed to the identification and validation of shared
sequence motifs experimentally as well as computationally,
these approaches, however, cannot be meaningfully applied
for the elucidation of the role of gene-specific promoter
sequences. At this time, the role of gene-specific sequences
can only be determined experimentally, on a gene to gene
basis. In this investigation, we have examined one such gene-
specific sequence adjoining the heat shock element (HSE) in
the proximal promoter of the small heat shock protein gene
αB-crystallin (cryab) and found it to be essential for expres-
sion both in cultured cells as well as in transgenic mice.
Cryab is the archetypical, conserved, small heat shock
protein gene expressed ubiquitously in multiple tissues
in vertebrates in a developmentally dictated fashion. Its
expression attends a host of pathologies ranging from
cardiomyopathies and cataracts to oncogenesis and neu-
rodegenerations such as Alzheimer's disease, multiple
sclerosis, and age-related macular degeneration [15,16].
In specific cell types, in culture, it is also expressed in
response to heat and osmotic stress [17-19].
A number of cis-regulatory elements including various
enhancers that regulate the expression of the cryab gene
in different tissues have been previously identified [20-23].
We have characterized the heat shock promoter of this
gene [18,24,25], which is highly conserved between rodents
and humans (see Figure 1A). It contains a canonical trimeric
HSE at −54/−40, which binds the heat shock transcription
factor 4 (HSF4) [25]. The HSE is part of the sequence
named HSE-αB, (Figure 1), a 30-bp promoter fragment
(−64/−35), which has been used previously for HSF4 bind-
ing assays in gel-shift experiments [24,25]. The canonical
HSE (15 bp) in the HSE-αB is flanked by gene-specific
10-bp on the 5′ end and 5 bp on the 3′ end (Figure 1).
Figure 1B graphically defines the 10-bp gene-specific se-
quence in comparison with a universal sequence motif
such as a transcription factor binding sequence like HSE
(there are many consensus HSEs in many genes); the 10-
bp gene-specific sequence adjoining the HSE on its 5′ end
is unique and is only present in the cryab gene. In this
investigation, we have examined the role of the gene-specific
sequences surrounding the canonical HSE (that makes the
HSE-αB sequence, −64/−35, Figure 1), in regulating the
cryab promoter activity in cultured human adult retinal
pigment epithelial cells (ARPE-19) and in transgenic mice.
Results
A 10-bp sequence in the cryab promoter is required for
expression in cultured ARPE cells
ARPE-19 is an established non-transformed epithelial
cell line, which naturally expresses αB-crystallin [26]. Asexpected [24,25], in transient transfections of ARPE-19,
promoter-reporter constructs containing mutations in
the HSE (−54/−40) reduced expression from the cryab
promoter appreciably. Both the complete (long) promoter
and the truncated promoter were used. We mutated
the sequences surrounding the HSE and followed the
expression of tGFP. Mutating or deleting the 5-bp sequence
from the 3′ end of the HSE does not impact expression
appreciably (Figure 2B). Interestingly, however, mutating
the 5′ gene-specific 10-bp sequence (−64/−55) adjoining
the HSE resulted in a more pronounced inhibition than
mutating the HSE (Figure 2A). In the typical experiment
shown in Figure 2A, mutations in trimeric HSE reduce the
expression by 40%–50% (Figure 2A, numbers 1–4), while
mutations in the 10-bp sequence adjoining the HSE
inhibit expression by 70%–80% (Figure 2A, numbers 1, 5,
and 6; note that mutating the dimeric HSE at −392/−383
did not alter these results). This pattern of the inhibition
of the promoter activity, obtained with mutated 10-bp
sequence adjoining the HSE was consistent both when
using the complete (−896/+44; Figure 2A, constructs 1–6)
as well as the truncated promoter (−64/+44; Figure 2A,
constructs 7–9). This is clearly an antithesis of what would
be expected because the 10-bp sequence is a gene-specific
sequence adjoining the canonical HSE. The canonical
HSE binds HSF4 and is present in many heat shock
promoters, thus considered to contain regulatory ‘infor-
mation’. The gene-specific sequence, on the other hand,
is only present in the αB-crystallin gene and is therefore
perceived to be devoid of any regulatory information.
Much against this perception, however, the 10-bp se-
quence adjoining the HSE seems to work in a context-
independent fashion. This is revealed by the observation
that the same level of inhibition is obtained when this se-
quence is mutated within a complete promoter (Figure 2A,
numbers 1–6) as well as when it is part of the truncated
version of the promoter (Figure 2A, numbers 7–9). In
comparison, when HSE (−54/−40) in the truncated pro-
moter is mutated, the inhibition of the expression is
not as pronounced as when the whole promoter is used
(Figure 2A, compare numbers 1 and 3 and numbers 7 and
8) reiterating the known context-dependent [27] function-
ing of individual promoter motifs or a transcription factor
binding site, in this case, the HSE. We conclude that the
5′ 10-bp sequence (−64/−55) adjoining the HSE contains
information that is required for expression from the cryab
promoter in human ARPE cells.
The 10-bp sequence functions in a position and
orientation-specific fashion
We further explored the status of the 10-bp sequence
(−64/−55), identified above, as an independent promoter
element. We deleted it (Figure 3A, number 2), reversed
its orientation without changing its position (Figure 3A,
Figure 1 The location of HSE-αB within the proximal promoter (−162/+44) of the cryab gene. (A) Human and rat sequences in the
proximal promoter of the cryab gene are highly conserved. The numbering shown above is for the rat sequence [20], TSS, transcription start site
(thick blue arrow). The promoter element HSE-αB (black line), a 30-nucleotide promoter sequence, was used for earlier gel-shift studies [24,25].
The TATA box (thin line) and the GPS (determined in this investigation) are boxed (thick line). The positions of two Pax6 sites [22] (pink) are shown.
(B) A graphic representation of the composition of HSE-αB (−64/−35). This plot was generated from the results of the BLASTN homology search of the
human genomic database using HSE-αB (x-axis), as the query sequence. Various parts of this sequence pick up homologous DNA sequences starting
with various start positions. We calculated the frequency of each start position. The y-axis shows the frequency of start positions with homology in
the 30-bp query sequence. Note that about 90% of the homology searches start from position 11 of this sequence. Position 11 is the first base of the
5'-NGAAN-3′ pentamer, the first of the three inverted sequence motifs (arrows) that make the HSE. There were no significant searches that start after
position 18. The inset contains a plot of relative information content per base (bits) at each of the 30 positions in the HSE-αB, derived from top 100
BLASTN hits using http://weblogo.berkeley.edu. Based on this analysis, we designate the first 10 bp as gene-specific promoter sequence (GPS), while
sequences from positions 11 to 25 constitute the canonical HSE (15 bp) with high-frequency representation in the genome. This analysis is based on
3,336 Blast hits using a maximum number of sequences = 20,000 in the NCBI BLASTN program.
Jing et al. Human Genomics 2014, 8:5 Page 3 of 13
http://www.humgenomics.com/content/8/1/5numbers 3 and 4), and changed its position without
reversing its orientation by placing it on the 3′ end of
HSE-αB sequences (Figure 3A, number 5). All of these
manipulations inhibit promoter activity (Figure 3A). This
data leads to the conclusion that the 10-bp sequence
adjoining the HSE on the 5′ end (−64/−55), unlike an
enhancer, contains positional information, which is
essential for the expression from the cryab promoter.We named this sequence as the gene-specific promoter
sequence (GPS).
Impact of GPS on promoter activity when moved to
various distances from the transcription start site
The GPS, when moved to the 3′ of the HSE-αB inhibits
expression (Figure 3A, number 5). The GPS was also
moved to −71, −154, −267, −392, and −496 (with
Figure 2 The 5′ 10-bp sequence adjoining the HSE controls the activity of the cryab promoter. (A) Cryab promoter sequences (−896/+1),
showing the dimeric HSE (−392/−383) and sequences from −64 to −23 that includes the trimeric HSE (numbers 1–6). The thin arrows on top of the
trimeric HSE (blue) indicate the 5'-NGAAN-3' inverted orientation of the HSE motifs. Mutations are indicated in red and underlined (numbers 2–6, 8, 9).
The complete promoter is −896 to +44, and the truncated promoter includes sequences −64 to +44. tGFP (green) starts with ATG. TSS is shown with
an arrow at +1. The dimeric HSE (−392/−383) and sequences at −64/−35 (HSE-αB) and −29/−23 (TATA box) are schematically represented with open
boxes in the promoter/reporter constructs. The corresponding activity of each construct (relative tGFP expression as assessed by RT-qPCR) is shown on
the right (means ± standard deviation). Note inhibition of tGFP expression (numbers 5, 6, 9) by mutations in the 10-bp sequence (−64/−55) adjoining
the HSE. The numbers (1 − 9) in the top panel with relevant sequences correspond to numbers for promoter/reporter constructions in the lower panel.
Note that deletion of the dimeric HSE at −392/−383 does not affect the reporter expression in these cells (1 and 2). (B) Sequences on the 3' end of the
trimeric HSE do not impact the expression significantly. Relevant sequences are shown on top. Mutations are indicated in red and are underlined. Sche-
matics of various constructions and the activity of each promoter/reporter construct, as assessed by RT-qPCR (means ± standard
deviation), is shown as in A. The key to various notations in A and B is given on the bottom.
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Figure 3 The 10-bp sequence functions optimally only in appropriate position and orientation. Schematic representations of various
constructions and corresponding activity profiles (RT-qPCR) are shown in (A) and (B). (A) Complete (−896/+44) cryab promoter/tGFP constructs
were used. The values shown are the means ± standard deviation. Note that all manipulations of the 10-bp sequence (−64/−55) have a drastic
inhibitory effect on tGFP expression. (B) Functional consequences (RT-qPCR) of moving GPS upstream to different distances from the TSS. (C) A
plot of the expression of tGFP as a function of the distance of GPS from TSS. Data from three separate experiments (EXP1-3) is plotted. Note that
the response is biphasic, and moving GPS to 5' upstream beyond −154 has an inhibitory effect on tGFP expression. The key to various notations
is given in the top right box.
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to 7, 90, 203, 328 and 432 bp upstream from its original
position (at −64/−55), respectively (Figure 3B). When
moved upstream to −71 or −154 positions, the effect
on expression is minimal (Figure 3B, numbers 6 and 7).
However, when moved farther than −154 bp from the
TSS, there is a precipitous loss of promoter activity
(Figure 3B, numbers 3–5).
It is important to note that the movement of the GPS
from its original site to a new site (Figure 3B) does not
disrupt any essential sequences required for expression.
GPS is part of one of the two consensus Pax6 binding
sites (−160/−140 and −77/−55) in the cryab promoter
(Figure 1A) [21-23,28]. Note that moving the GPS
from −64 to −71, which disrupts the proximal Pax6site, hardly impacts the expression (Figure 3B, number 7)
as does the placement of the GPS at −154, which disrupts
the distal Pax6 site (see Figure 1A), reducing the expres-
sion only by about 15% (Figure 3B, number 6) suggesting
that neither Pax6 site significantly contributes to the
expression from the cryab promoter in ARPE cells in
culture.
In the mouse cryab promoter, sequences downstream
of −426 have been shown to be enough for expression in
transgenic mice [22]; thus, moving the GPS to −496
(Figure 3B, number 3) should have minimal impact on
the expression, yet this manipulation also inhibits the
expression. Therefore, it is the absence of GPS from its
appropriate place rather than its movement to a new
place that results in the inhibition of the cryab promoter
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movement of the GPS to any position (Figure 3B, num-
bers 3-7), 5′ to its natural position (−64/-55), has a grad-
ual impact on the expression. In comparison, when GPS
is moved 20 bp 3′ to its original position (−55), the ex-
pression is completely blocked (see Figure 3A, number
5). It is important to note that all the manipulations
(point mutations and deletions) show similar results
(Figure 4), indicating that structural perturbations, if
any, do not affect the promoter activities assayed here
(Figures 2 and 3).
GPS is required for expression in transgenic mice
We next ascertained if GPS controls the expression from
the cryab promoter in the whole animal. Transgenic mice
were produced with complete rat cryab promoter-turbo
green fluorescent protein (tGFP) constructs (see Figure 5A)
with (+GPS) and without GPS (ΔGPS). αB-crystallin is
expressed very early in the developing heart and the ocular
lens [29,30]. Accordingly, in transgenic mice containing
the wild-type promoter (+GPS), the expression of tGFP
as detected by immunohistochemistry is seen in the
developing eye and the heart. In animals made without
the GPS (ΔGPS), no tGFP expression is seen (Figure 5C,Figure 4 Comparison of point mutations versus deletions on the tGFP
constructions were used as in Figures 2 and 3. Expression of tGFP was asse
and deletions (in HSE and GPS) have the same relative effect on the tGFP exp
alterations in the 10-bp sequence have a more pronounced effect on the tGF
number 5 with 4). The construction (number 6) contains deletions of both
on activity is similar to that obtained with deletion of the 10-bp sequence (GP
constructs numbers 3 and 5, respectively, in Figure 2A. The key to the schemabottom panels). In Figure 5C, confocal images of middle z
sections from three tissues each (eye, heart, and liver)
from three transgenic lines (numbers 1–3) have been
shown. Interestingly, in the liver, αB is known to be
expressed only in stellate cells [31]. This is confirmed
here by the specific detection of tGFP in these cells in
the livers of transgenic mice containing GPS (+GPS). In
transgenic animals produced without the GPS (ΔGPS), the
tGFP expression is absent (Figure 5C). The immunohisto-
chemistry data was further corroborated by immunoblot-
ting of 11 different tissues from the F1 (Figure 5D) and
F2 generation transgenic mice (Figure 5E). This data
establishes that no tGFP transgene expression is detected
in transgenic animals generated with recombinant con-
structs without GPS (ΔGPS) (Figure 5).
αB-crystallin is known to be expressed at high levels in
the lens, but the tGFP protein levels detected in the trans-
genic lens are much lower (immunoblots in Figure 5D,E).
However, it is the tGFP transcript levels that should be
considered more relevant to the expression than the
absolute amount of tGFP protein. The detection of tGFP
protein levels may be masked by normally high concen-
trations of crystallin proteins in the lens and/or poor
translation of the transgenic mRNA in comparison withexpression driven by cryab promoter. Complete promoter
ssed by RT-qPCR of total RNA. Note that both the point mutations
ression (compare numbers 2 and 5 and numbers 3 and 4). Importantly,
P expression than alterations in the HSE (compare number 2 with 3 and
the 10-bp sequence (GPS) as well as the HSE. Interestingly, the effect
S) alone (number 4). The constructs numbers 2 and 3 correspond to
tics is given at the bottom.
Figure 5 Cryab promoter without GPS (ΔGPS) is inactive in transgenic mice. (A) Schematic of the + GPS cryab promoter-tGFP transgene
(GPS, blue rectangle). Primer locations for genotyping are shown. (B) Genotyping of transgenic mice, F forward primer, R reverse primer. Note the
lower mobility of the PCR product (270 bp, left panel) generated from ΔGPS mice in comparison with the (+)GPS mice (280 bp). The right panel
(with 2F and 2R, internal for tGFP) shows no change in amplicon size (290 bp). WT wild-type non-transgenic DNA, Blk blank. (C) Expression of tGFP
(anti-tGFP immunofluorescence, confocal images) in three transgenic mouse lines (numbers 1–3) in + GPS and ΔGPS mice. Middle z sections of three
tissues (eye, heart, and liver) are shown from+ GPS (top) and ΔGPS mice (bottom). In + GPS transgenic tissues, tGFP immunofluorescence is obvious in
both the developing heart (ve ventricle) and the eye (ocular lens (le), corneal epithelium (ce), and ganglion cells (gc)). In addition, tGFP expression is
seen in the surrounding choroid and mesenchymal cells between the lens and the developing retina. The specific expression of tGFP in hepatic stellate
cells (sc) is striking (+GPS, liver). Note the absence of expression (immunofluorescence) in the ΔGPS lines in all tissues (bottom). (D) Immunoblots of 11
tissue extracts of F1, (+)GPS and ΔGPS (transgenic line 2), and WT. Gapdh green bands (internal control). Le lens, Re retina, Eg eye globe without the lens
and retina, Li liver, He heart, Lu lung, Sp spleen, Ki kidney, Si small intestine, Mu muscle, Br brain, C control ARPE-19 cell extract. (E) Immunoblots of tissue
extracts as in (D) from F2, line 2 transgenic animals. Note that the WT and ΔGPS tissues do not show any reactivity for tGFP.
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detects high levels of tGFP transcripts in the lens, retina,
heart, kidney, and the brain in + GPS animals (Figure 6).
However, the absolute requirement for the presence of
GPS in the cryab promoter is established by the absence
of tGFP transcripts in all the tissues examined in ΔGPS
animals (Figure 6).Discussion
In a multicellular organism, differential gene activity is
the outcome of the initial decision that a cell makes
whether a particular gene should be active or inactive
followed by the modulation of the gene activity by the
tissue/organ function. The data presented here demon-
strates an overriding requirement for a GPS in the
Figure 6 GPS is essential for the cryab promoter activity in transgenic mice. Relative tGFP expression was assayed in transgenic mice with
GPS (+GPS), without GPS (ΔGPS) and wild type non-transgenic mice (WT). RT-qPCR analysis of tGFP expression in 11 mouse tissues is shown.
Two transgenic lines and two WTs were analyzed, but no tissues were pooled. No tGFP is seen in ΔGPS and WT animals. Le lens, Re retina, Eg eye
globe without the lens and retina, Li liver, He heart, Lu lung, Sp spleen, Ki kidney, Si small intestine, Mu muscle, Br brain. The inset is a screen shot
of the raw data from the 480 cycler (Roche).The dotted vertical line separates the + GPS samples from the ΔGPS and WT samples.
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well as in the transgenic mice (Figures 2, 3, 4, 5, and 6).
Significantly, the GPS, unlike an enhancer, is position
and orientation-specific (Figure 3).
The proximity of the GPS to the TSS and its orientation
and position-specific function in the cryab promoter may
suggest a simpler and direct mechanism of gene-specific
control through its involvement with the development of
transcriptional competence (or opening up of a promoter)
[32]. The analysis presented here, however, does not
preclude the existence of GPS-like elements at longer
distances from the TSS in the eukaryotic promoters. It
is interesting to note that sequences 100 bp upstream
of the TSS have been previously suggested to control
the lymphoid cell specificity of the expression from a κ-
light chain immunoglobulin promoter [33].
The GPS identified here is either a binding site or a
hub for transacting factor(s) or simply a landmark that
dictates the physical state of the chromatin that allows
gene activity [34-39]. The data presented in Figure 3
provides significant insight about the relationship between
expression and the location of the GPS (distance of this
sequence from the TSS). We know that changing the
location of the GPS from the 5′ to the 3′ side of HSE-
αB inhibits expression (Figure 3A, number 5). However,
moving it more than 90 bp, 5′ upstream of the HSE
(−64/−35), reduces the promoter activity marginally
(Figure 3B, number 6). This tolerance to change in
location, 5′ upstream of the HSE, becomes unacceptable
when the GPS is moved more than 154 bp from the TSS,
which results in drastic inhibition of the promoter activity
(Figure 3B, numbers 2–5). A plot of the expression versusdistance of the GPS from the TSS indicates a biphasic re-
sponse, a slow less dramatic phase when at positions −71
and −154 and a fast declining component beyond −154
(Figure 3C). This data leads to two important inferences:
(1) GPS must remain in proximity of the TSS, 5′ to the
HSE to be functional, and (2) considering that 154 bp is
roughly the size of DNA wrapped around a nucleosome
bead, the GPS may have an influence on nucleosome
spacing and/or the physical status of the nucleosomes in
the vicinity of the TSS [35,36]. It is known that HSF4 (that
binds to the HSE) has been reported to recruit BRG1
(Brahma-related gene 1), a member of the chromatin
remodeling complex to cryab promoter [38,39] suggest-
ing a possible function of the GPS via positioning of
the nucleosomes in regulating access to the promoter.
While it remains to be established if trans-acting factor
binding sites (including transcription factors) become
functional only in the presence of a GPS, it is tempting
to speculate that the apparent promiscuity in some DNA
binding transcription factors, e.g., Pax6 [37,40] and
possibly HSF4, may be brought about by gene-specific
sequences like the GPS.
We have demonstrated recently that HSF4 is detected
on the cryab promoter in ARPE cells indicative of its
involvement in the expression from this promoter [18]. In
light of this observation, the inhibition of the promoter
activity upon deletion of GPS (Figure 3A, number 2) or
upon change of its position (Figure 3A, number 5) sug-
gests that HSF4 binding to HSE is not enough for eliciting
gene activity but may also require a functional GPS. If this
interpretation is extrapolated to the data obtained with
transgenic mice, it is obvious that GPS may be essential
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by the complete inhibition of cryab promoter activity in
multiple tissues in transgenic mice made with constructs
without the GPS (ΔGPS) in comparison with constructs
that contained GPS (+GPS) (Figures 5 and 6). These data
suggest that GPS may be obligatory for the activation of
cryab transcription.
GPS is a gene-specific sequence. The mechanism of
its involvement in regulating the heat shock promoter
of the cryab gene can only be speculated at this time
(Figure 7). It is possible that the efficiency of the binding
of trans-acting factors to their cognate sites is dictated
by the gene-specific promoter sequences, in which case
it would explain how numerous binding sites all over
the genome [4] would not be productive because of theFigure 7 Hypothetical schemes of GPS involvement in regulating
cryab promoter activity. The schematics shown are based on the
observation that cryab promoter cannot function without the GPS.
Without the GPS, the interaction of the HSF4 with the HSE is weak
(indicated by monomeric interaction of HSF with HSE) and therefore
non-productive (red X) (A). GPS presence could simply enhance binding
of HSF4 to the HSE by itself (B) or by binding to another transacting
factor that could be a protein (C) or an RNA (D). On the other hand,
GPS could act as a chromosomal landmark for the open promoter. This
may involve protein-DNA as well as protein-protein interactions (E) that
would facilitate HSF4 binding to the HSE as well as opening of the
promoter for transcriptional activity. We do not know what comes first:
the involvement of the GPS, or the binding of HSF4 in the events that
lead to the activation of the cryab promoter? The data presented in this
investigation suggests that the involvement of the GPS must precede
any event(s) that leads to cryab promoter activation.absence of the GPS. That this may be the case is indi-
cated by the early gel-shift studies, wherein we mutated
the GPS in the 32P-HSE-αB probe and assayed its effect
on the appearance of the HSE-HSF4 complex (complex
III) in the nuclear extracts of the post-natal day 10 rat
lens (Figure 8). Mutations introduced into the GPS sig-
nificantly diminished the generation of the HSE-HSF4
complex formation (Figure 8). This in vitro data sug-
gests that the GPS has a role in HSF4 binding. It is also
possible that the gene-specific sequence binds a protein
or an RNA that cooperatively impacts the productive
binding of the transacting factor. Alternatively, the GPS
may be modulated by local physiology and/or the develop-
mental state via RNA or a protein binding factor. These
speculations need to be investigated experimentally for a
complete understanding of the role of gene-specific se-
quences in eukaryotic promoter regulation.Figure 8 Gel-shift analyses with 32P-HSEαB and its mutants.
Post-natal day 10 rat lens nuclear extracts, which predominantly
contain HSF4 [25], were used for these assays. Autoradiograph shows
the complex III (lane HSEαB), the major complex, which contains trimeric
HSF4, known to be associated with the active promoter. The two minor
complexes (I and II), seen mostly when the heat shock promoter is not
active, are not seen here clearly. TSS transcription start site. M1–M3 are
probes with mutations in one or two of the 5′-NGAAN-3′ motifs (arrows)
of the trimeric HSE (blue), as expected [24,25] they do not bind HSF4.
M4 and M4X are two HSEαB mutant probes with alterations in the GPS.
Both these probes have diminished HSF4 binding activity (complex III)
when compared to wild-type probe, HSE-αB. All mutations are
shown in red and are underlined. All the probes are 30-bp long and
had comparable specific activities.
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We have identified a non-enhancer gene-specific, position-
and orientation-dictated 10-bp sequence (GPS) within
the heat shock promoter of the αB-crystallin gene that
is required for expression from this promoter, in cultured
cells as well as in transgenic mice. The data presented
here brings up three important corollaries: (1) Since
GPS is essential for expression even before transcription
factors and/or enhancer sequences get involved, the initial
activation of a gene may be dictated by the gene-specific
information in the promoter DNA. (2) Because GPS se-
quences do not represent universal motifs, they cannot be
computed. Thus, they may have to be identified through
labor-intensive experimentation as done here on a gene-
to-gene basis. (3) GPS sequences could become targets for
manipulation of a cell's phenotype.
Methods
Construction of recombinant plasmids
A 940-bp DNA fragment, −896/+44 (upstream of the
ATG in the first exon of the αB gene) was amplified
from the rat (Sprague Dawley) genomic DNA using
primers: F (forward) 5′-ATAGTGCCGAGCCTCTTG-3′
and R (reverse) 5′-GGGAGTGGAAAGGAAAGAA-3′
and cloned into pTOPO4 vector (Invitrogen, Carlsbad,
CA, USA). This promoter sequence in pTOPO4 was
used as the template for all downstream manipulations.
The −896/+44 sequences represent complete rat cryab
promoter. Beyond −896, there is another gene (HspB2),
which is transcribed in the opposite orientation [41].
Two promoter constructs (αB-tGFP plasmids) were
made: the truncated version (−64/+44) and the whole
promoter (−896/+44) (Figures 2 and 3). These two con-
structs were made by amplifying two different lengths
of the 5′-flanking region of the cryab promoter using
one common downstream primer (+44R 5′-ATCTAA
GGATCCGATGGCTAGATGAGTGTAGAGTCG-3′) and
two upstream primers (−896 F 5′-ATCTAAGAATTCA
CACCACCCAAAATAGTGCAGAGC-3′ and −64 F 5′-
ATCTAAGAATTCTGACATCACCGTTCCAGAAGCTT
C-3′), respectively. These PCR products were gel puri-
fied and cloned into pTurbo-GFP-pRL (Axxora LLC.,
San Diego, CA, USA). The tGFP sequences start with an
ATG. All mutations were introduced using commercially
available site-directed mutagenesis PCR kit (Agilent, Santa
Clara, CA, USA) and verified by sequencing. The se-
quences of the primers used for these manipulations are
listed in Table 1.
Cell culture and transfection experiments
ARPE-19 cells (ATCC, Manassas, VA, USA) [26] at 70%
to 90% confluence were transfected with a mixture of
experimental αB-tGFP plasmid DNA and pCMV-DsRed
vector (Clontech, Mountain View, CA, USA) (50:1) usingLipofectamine2000 (Invitrogen). The pCMV-DsRed plas-
mid was used as an internal standard to normalize trans-
fection efficiency. The experiments were done in triplicate
and repeated three times.Transgenic mice and genotyping
The animal care and use protocol were followed as per
institutional guidelines of the Animal Research Commit-
tee, University of California, Los Angeles, CA, USA. The
whole promoter αB-tGFP constructs with or without
GPS (construct with GPS shown in Figure 5A) were
double digested with Xho I and Afl II to obtain a 2-kb
fragment containing polyA signal (polyA is from the
backbone of pTurbo-GFP-pRL plasmid). The fragment
(αB-tGFP-polyA) was purified from the vector backbone
and used for the generation of transgenic mice [42] at
the UCLA Transgenic/Knockout Injection Facility. We
generated five founders for + GPS and nine founders for
ΔGPS constructs. Three lines each for + GPS and ΔGPS
were examined for expression of the tGFP.
Genotyping was performed using PureLink™ Genomic
DNA Mini Kit (Invitrogen) employing two primer sets
(1F 5′-GTGTCACCCTGCCAAATC-3′, 1R 5′-GCTCGA
ACTCCACGCCGTT-3′; 2F 5′-GCCACCATGGAGAGC
GACGAGA-3′, 2R 5′-GATGCGGGTGTTGGTGTAG-3′).
To determine the copy number of αB-tGFP inserts in
different transgenic strains, absolute qPCR assays were
performed with 10-ng genomic DNA using the Light-
Cycler 480 SYBR Master Mix (Roche, Indianapolis, IN,
USA) [43,44]. The whole promoter αB-tGFP constructs
were serial diluted as template, and four different amounts
of DNA (1 ng, 100, 10, and 1 pg) were used in a 10-μl
reaction for the generation of the standard curve. All
reactions were done in triplicate. The qPCR thermal
cycling conditions were as follows: 95°C for 5 min for
hot start, followed by 45 cycles of 95°C for 15 s, 56°C
for 20 s, and 72°C for 30 s. Specific primers were used
in SYBR Green qPCRs were as follows: tGFP: 2F 5′-
GCCACCATGGAGAGCGACGAGA-3′, 2R 5′-GATGCG
GGTGTTGGTGTAG-3′. The average copy number in +
GPS and ΔGPS transgenic mice were determined to be
6.2 and 18.0, respectively.Confocal microscopy and immunofluorescence
The whole embryos from +GPS (embryonic day 16, E16)
and ΔGPS transgenic mice (embryonic day 15, E15)
were fixed in 4% paraformaldehyde and processed as
detailed previously [45] using anti-tGFP antibody (Axxora
LLC., San Diego, CA, USA). Serial z-stack images were
acquired from the whole eye, heart, and liver using a
confocal microscope (FluoView 1000, Olympus, Tokyo,
Japan) and processed using Adobe Photoshop Elements
version 9.
Table 1 Oligonucleotides used in site- directed mutagenesis
Primer set number Sequence Figure/construct number
1 Sense: 5'-GCTCAGCCCAGCGAAATTTCAGCCTCTGCCCAGG-3' Figure 2A/number 2
Antisense: 5'-CCTGGGCAGAGGCTGAAATTTCGCTGGGCTGAGC-3'
2 Sense: 5'-CCCTGACATCACCATTACACGATCTTTACAAGACTGCATATA-3' Figure 2A/number 3
Antisense: 5'-TATATGCAGTCTTGTAAAGATCGTGTAATGGTGATGTCAGGG-3'
3 Sense: 5'-ATAATAAAACCCCCAGTGCTGTTGTTCCAGAAGCTTCACAAGAC-3' Figure 2A/number 5
Antisense: 5'-GTCTTGTGAAGCTTCTGGAACAACAGCACTGGGGGTTTTATTAT-3'
4 Sense: 5'-CGAGCTCAAGCTTCGAATTCCAGTGCTGTTGTTCCAGAAGCTTCAC-3' Figure 2A/number 9
Antisense: 5'-GTGAAGCTTCTGGAACAACAGCACTGGAATTCGAAGCTTGAGCTCG-3'
5 Sense: 5'-CCGTTCCAGAAGCTTCACAAGCCTGCATATATAAGGGGC-3' Figure 2B/number 2
Antisense: 5'-GCCCCTTATATATGCAGGCTTGTGAAGCTTCTGGAACGG-3'
6 Sense: 5'-CCGTTCCAGAAGCTTCAACCGACTGCATATATAAGGGGCAGGC-3' Figure 2B/number 3
Antisense: 5'-GCCTGCCCCTTATATATGCAGTCGGTTGAAGCTTCTGGAACGG-3'
7 Sense: 5'-CCTGACATCACCGTTCCAGAAGCTTCACTGCATATATAAGGGGCAGGCTG-3' Figure 2B/number 4
Antisense: 5'-CAGCCTGCCCCTTATATATGCAGTGAAGCTTCTGGAACGGTGATGTCAGG-3'
8 Sense: 5'-GCTGGGATAATAAAACCCCGGTGATGTCAGTTCCAGAAGCTTCACAAG-3' Figure 3A/number 3
Antisense: 5'-CTTGTGAAGCTTCTGGAACTGACATCACCGGGGTTTTATTATCCCAGC-3'
9 Sense: 5'-GCTGGGATAATAAAACCCCCCACTACAGTGTTCCAGAAGCTTCACAAG-3' Figure 3A/number 4
Antisense: 5′-CTTGTGAAGCTTCTGGAACACTGTAGTGGGGGGTTTTATTATCCCAGC-3'
10 Sense: 5'-CCAGAAGCTTCACAAGATGACATCACCCTGCATATATAAGGGGC-3' Figure 3A/number 5
Antisense: 5'-GCCCCTTATATATGCAGGGTGATGTCATCTTGTGAAGCTTCTGG-3'
11 Sense: 5'-GGGATAATAAAACCCCGTTCCAGAAGCTTCAC-3' Figure 3B/number 2
Antisense: 5'-GTGAAGCTTCTGGAACGGGGTTTTATTATCCC-3'
12 Sense: 5'-GACACCTAGTTCTGACATGACATCACCTATTGGTGGTCACAGCTCTCC-3' Figure 3B/number 3
Antisense: 5'-GGAGAGCTGTGACCACCAATAGGTGATGTCATGTCAGAACTAGGTGTC-3'
13 Sense: 3'-CCCTGGGGCTCAGCCCATGACATCACCGGAAGATTCCAGCCTCTGCC-3' Figure 3B/number 4
Antisense: 5'-GGCAGAGGCTGGAATCTTCCGGTGATGTCATGGGCTGAGCCCCAGGG-3'
14 Sense: 5'-CTGGCTCCAGAGAACAAGTGACATCACCGATGGGGTGGGTGGGTGCC-3' Figure 3B/number 5
Antisense: 5'-GGCACCCACCCACCCCATCGGTGATGTCACTTGTTCTCTGGAGCCAG-3'
15 Sense: 5'-CTTTTCTTAGCTCAGTGAGTGACATCACCTACTGGGTATGTGTCACC-3' Figure 3B/number 6
Antisense: 5'-GGTGACACATACCCAGTAGGTGATGTCACTCACTGAGCTAAGAAAAG-3'
16 Sense: 5'-GGGGAGCTGGGATAATAATGACATCACCAACCCCGTTCCAGAAGC-3' Figure 3B/number 7
Antisense: 5'-GCTTCTGGAACGGGGTTGGTGATGTCATTATTATCCCAGCTCCCC-3'
17 Sense: 5'-CCCCTGACATCACCCAAGACTGCATATATAAGGGG-3' Figure 4/number 5
Antisense: 5'-CCCCTTATATATGCAGTCTTGGGTGATGTCAGGGG-3'
18 Sense: 5'-GCTGGGATAATAAAACCCCCAAGACTGCATATATAAGGGGC-3' Figure 4/number 6
Antisense: 5'-GCCCCTTATATATGCAGTCTTGGGGGTTTTATTATCCCAGC-3'
The last column lists the associated figures. The mutated sequences are italicized.
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Mouse tissue extracts (post-natal, day 10 pups) were
prepared in T-PER Protein Extraction Reagent (Pierce,
Rockford, IL, USA). About 30 μg of protein/lane was
electrophoresed on 4% to 12% SDS-PAGE gradient gels
(Invitrogen) and transferred to nitrocellulose membranes
for immunoblotting [26]. The reactive protein bands
(anti-tGFP) were quantified using the LiCOR Odysseydual wavelength IR system (LiCOR Biosciences, Lincoln,
NE, USA). Gapdh was used as an internal control for all
blots. Similar data was obtained with three lines of + GPS
and ΔGPS transgenic lines.
Total RNAs were extracted 48 h after transfection of
ARPE cells or from mouse tissues using TRIzol Plus RNA
Purification System (Invitrogen, Carlsbad, CA, USA). RT-
qPCR was conducted as described [18]. RT-qPCRs were
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cycler 480 (Roche) (95°C for 5 min, followed by 45 cycles
of 95°C for 15 s, 56°C for 20 s, and 72°C for 30 s). To
calculate the relative change of tGFP expression, PCRs
were normalized with reference to corresponding internal
controls (DsRed RNA isolated for transiently transfected
APRE-19 cells and Gapdh RNA for transgenic and wild-
type mice tissues using the ΔΔCt method) and expressed
as a percentage of the wild-type construct. Specific
primers used were as follows: tGFP: F 5′-CTACC
ACTTCGGCACCTACC-3′, and R 5′-GATGCGGG
TGTTGGTGTAG-3′; DsRed: F 5′-TACCTGGTGGA
GTTCAAGTCC-3′ and R 5′-TCGTTGTGGGAGGTG
ATGT-3′. Gapdh: F 5′-GGTGAAGGTCGGTGTGA
ACG-3′ and R 5′-CTCGCTCCTGGAAGATGGTG-3′.
We also assessed expression of tGFP in transfected ARPE
cells (Figures 2, 3, and 4) with immunoblotting. This data
mirrored the RT-qPCR data and is therefore not shown.
Gel-shift
These experiments were done with 32P-labeled HSE-αB
probes as previously described [24,25].
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